The potential role of Bi-specific antibodies in acute myeloid leukemia

被引：4

作者：

Yilmaz, Musa ^{[1
]}

Ravandi, Farhad ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1400 Holcombe Blvd,Unit 428, Houston, TX 77030 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2020年 / 33卷 / 04期

关键词：

Bispecific antibody; BiTE; DART; BiKE; TriKE; Tandem antibody; AML; Immunotherapy; T-CELL ENGAGER; RECEPTOR-ALPHA CHAIN; STEM-CELL; MACROPHAGE ACTIVATION; MONOCLONAL-ANTIBODY; AMG; 330; TARGET; EXPRESSION; CD123; CD33;

D O I：

10.1016/j.beha.2020.101218

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bispecific antibodies consist of antigen recognition sites from two or more antibodies redirecting effector immune cell against target on tumor cells. Rapidly evolving medical technologies enabled engineering and development of recombinant protein products, and this, combined with interest from the pharmaceutical industry, further advanced the bispecific antibody research. Over 50 different types of bispecific antibody constructs are now being manufactured and explored in ongoing or future clinical trials. In this review, we will summarize the available data for bispecific antibodies developed and being investigated for the treatment of patients with acute myeloid leukemia.

引用

页数：7

共 50 条

[41] The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia
Briski, Robert
Garcia-Manero, Guillermo
Kantarjian, Hagop
Ravandi, Farhad
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
[42] Acute myeloid leukemia: Therapy resistance and a potential role for tetraspanin membrane scaffolds
Floren, Muskan
Gillette, Jennifer M.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2021, 137
[43] Bi-specific antibodies targeting signaling pathway crosstalk are a new breast cancer immunotherapeutic strategy
Zhang, Yanliang
Gros, Edwige
Chagar, Sarabjit
Cao, Jian
Zhou, Heyue
Motamed, Kouros
Kaufmann, Gunnar F.
Fu, Yanwen
CANCER RESEARCH, 2015, 75
[44] Review of bi-specific therapies in uveal melanoma
Marlana Orloff
Rino Seedor
Takami Sato
Cancer Gene Therapy, 2022, 29 : 1814 - 1818
[45] Nanoparticles as potential therapeutics for acute myeloid leukemia
Simmet, Thomas
Gaiser, Ann Kathrin
Schmiech, Michael
Syrovets, Tatiana
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[46] Review of bi-specific therapies in uveal melanoma
Orloff, Marlana
Seedor, Rino
Sato, Takami
CANCER GENE THERAPY, 2022, 29 (12) : 1814 - 1818
[47] Bi-specific antibody therapy for the treatment of cancer
Withoff, S
Helfrich, W
de Leij, LFMH
Molema, G
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (01) : 53 - 62
[48] The role of autophagy in acute myeloid leukemia development
Bednarczyk, Martyna
Kociszewska, Karolina
Grosicka, Olga
Grosicki, Sebastian
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (01) : 5 - 18
[49] The Important Role of Immunotherapies in Acute Myeloid Leukemia
Greiner, Jochen
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
[50] The role of quizartinib in the treatment of acute myeloid leukemia
Ostronoff, Fabiana
Estey, Elihu
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (12) : 1659 - 1669

← 1 2 3 4 5 →